• Home page
  • CML Experts
    • Team of experts on CML who developed imatinib>
      • Dr. Elisabeth Buchdunger
      • Dr. Brian Druker
      • Dr. John Goldman
      • Dr. Nora C. Heisterkamp
      • Dr. David Hungerford
      • Dr. Nicholas Lydon
      • Dr. Alex Matter
      • Dr. Felix Mitelman
      • Dr. Peter C. Nowell
      • Dr. Carlo Gambacorti-Passerini
      • Dr. Moshe Talpaz
      • Dr. Janet D. Rowley
      • Dr. Charles Sawyers
      • Dr. Jürg Zimmermann
      • Dr. Owen Witte
    • Experts involved in developing dasatinib>
      • Dr. Jagabandhu Das
    • Other CML experts in America>
      • Other CML experts in Canada>
        • Dr. Sarit Assouline
        • Dr. Lambert Busque
        • Dr. Robert Delage
        • Dr. Josée Hébert
        • Dr. Pierre Laneuville
        • Dr. Jeffrey H Lipton
        • Dr. Luigina Mollica
      • Other CML experts in US>
        • Carolyn Blasdel, RN , FNP-BC, OCN
        • PATRICIA JAKEL, RN, MN, AOCN
        • Rey Garcia, RN, BSN
        • Dr. Jorge E. Cortes
        • Dr. Arul Chinnaiyan
        • Dr. Michael Deininger
        • Dr. James D. Griffin
        • Dr. Frank Giles
        • Dr. Elias J. Jabbour
        • Dr. Hagop Kantarjian
        • Dr. Richard A. Larson
        • Dr. Alison Loren
        • Dr. Michael Mauro
        • Dr. Stephen D. Nimer
        • Dr. Ruben A. Mesa
        • Dr. Susan M. O'Brien
        • Dr. Jerald P. Radich
        • Dr. Karen Seiter
        • Dr. Neil Shah
        • Dr. Richard Stone
        • Dr. Raoul Tibes
        • Dr. Bin Zhang
    • Other CML Experts in Europe>
      • Dr. Jane Apperley
      • Dr. Michele Baccarani
      • Pr. Agnès Buzyn
      • Dr. Gabriel Etienne
      • Dr. François Guilhot
      • Dr. Eliane Gluckman
      • Dr. Andreas Hochhaus
      • Dr. Tessa L Holyoake
      • Dr. Hana Klamova
      • Dr. Jeroen J.W.M. Janssen
      • Dr. Franck-Emmanuel Nicolini
      • Dr. Delphine Rea
      • Dr. Johan Richter
      • Dr. Philippe Rousselot
      • Dr. Giuseppe Saglio
      • Dr. François-Xavier Mahon
    • Other CML experts in Asia>
      • Dr. Charles Chuah
      • Dr. Goh Yeow Tee
      • Dr. Pankaj Malhotra
      • Dr. Kim Dong-Wook
    • Other CML experts in Australia>
      • Dr. Susan Branford
      • Pr Tim Hughes
      • Dr. Anthony P Schwarer
  • Medical Concepts
    • Introduction to CML
    • Blood
    • Bone Marrow
    • DNA
    • Immune System>
      • Natural killer cell - NK
      • T Cells
    • JAK2 Gene
    • Treatment response in CML
    • Polymerase Chain Reaction
    • Stem Cells
    • Donor lymphocyte infusion (DLI)
    • Blood-Brain Barrier
    • Myeloproliferative disorders (MPD)>
      • Chronic Myeloid Leukemia (CML)
      • Essential Thrombocythemia (ET)
      • Myelofibrosis (MF)
      • Polycythemia Vera (PV)
    • Types of leukemia
  • Medication
    • Hydroxyurea
    • Interferon Alpha
    • Gleevec (Imatinib)
    • Tasigna (Nilotinib)
    • Sprycel (Dasatinib)
    • Bosulif (Bosutinib)
    • (Bafetinib)
    • (Danusertib)
    • Iclusig (Ponatinib)
    • (Rebastinib)
    • Synribo (Omacetaxine )
    • Supect (Radotinib)
    • Vidaza (Azacitidine)
  • Managing side effects
    • List of side effets>
      • Bone Pain
      • Depression
      • Eyes
      • Ear
      • Fatigue
      • Fluid Retention
      • Gastrointestinal system
      • Hair
      • Heart
      • Kidney
      • Muscle cramping
      • Pleural effusion
      • Skin
    • Art Therapy>
      • Art Therapist
      • CMLer's portofolio
    • CML and Nutrition
    • Massage therapy
    • Music therapy>
      • YouTube creation by CMLer's family
      • Adagio for Strings (Samuel Barber)
      • Magnificent (I Believe)
    • Physical Activity
    • Psycho-Oncology
    • Professionnel help and literature
    • Yoga
    • Zootherapy
  • Patient Testimonials
    • Gary Gonzales
    • Pat Elliott
    • Erin Havel (Author)
    • Erin Zammett Ruddy
    • Rob Shick
    • Virginia Garner
    • Laura Boyd
    • Drew Johnston
    • Royston Hogan
    • Doug Jenson
    • Rich Jones
    • Kevin Williams
    • Jan Geissler
    • Jean McGlynn
    • Tamera Simonson
    • Hans Loland
    • Christopher
    • Alexa Score
    • Austin Granatowicz
    • Judy Telford
    • Tom Cleaver
    • Others testimonials
    • Some celebrities>
      • Tim Holcomb
      • Doris Muramatsu
      • Ryan O'Neal
      • Kelvin Alston
      • Kareem Abdul-Jabar
      • Jason Blake
      • Rick Upchurch
    • Bud Romine - the first patient
    • Kayla Naton (Pregnancy)
    • Suzan Mc Namara and the petition
  • Blogs
    • Trey's CML Leukemia Blog
    • Living with CML
    • CMKID's blog – Dislodging the bullet
    • CML Recovery - Stopping KTI
    • Hans's Blog
    • Elizabeth's Blog - my leukemia journey
    • Elizabeth's Blog - Heart of the rose
    • Ian's Blog
    • Joe's Blog
    • Jon's Blog
    • Josh's Blog
    • Justin Ozuna's Blog
    • Lisa's Blog
    • Mannan's Blog
    • Matt's Blog
    • Matthew's Blog
    • Michelle's Blog
    • Michelle D's Blog
    • Nayree's Blog
    • Rob's Blog
  • News on CML (Chronic myeloid leukemia)
    • English
    • French (Français)
    • Spanish (Español)
  • Various topics
    • You’ve just been diagnosed
    • History of CML
    • CML causes
    • Food and Drug Interactions
    • Bone marrow transplant
    • Stem cells from umbilical cord blood
    • Children with CML
    • CML and pregnancy
    • Cure possible for CML?>
      • CML vaccine
      • Can immunotherapy cure leukemia?
      • Feverfew extract (parthenolide)
      • Possible cure for CML in Fish Oil
      • Can dandelions kill cancer?
      • Can genetic sequencing help to cure leukemia?
      • Can curcumin cure leukemia?
      • Can the new drug CX-5461 cure leukemia?
      • Betel leaf may help fight CML
      • Math could help cure leukemia
    • The French trial called STIM (Stop Imatinib)
    • Mutation T315I
    • Elderly patients with CML
    • Living with CML and diabetes
    • Sports with CML
    • Pronostic, quality of life ....
    • CML Awareness Day
  • Congresses, conferences, meetings ASH, ASCO, EHA ...
    • ASCO 2013 - Chicago
    • ASCO 2012 - Chicago
    • ASCO 2011 - Chicago
    • ASCO 2010 - Chicago
    • ASH 2012 - Atlanta
    • ASH 2011 - San Diego
    • ASH 2010 - Orlando
    • ASH 2009 - New Orleans
    • BTG 2011 - Singapore (Singapore)
    • EHA 2013 - Stockholm (Sweden)
    • EHA 2012 - Amsterdam (The Netherlands)
    • EHA 2011 - London (England)
    • EHA 2010 - Cascais (Portugal)
    • EHA 2009 - Berlin (Germany)
    • EHA 2008 - Copenhague (Danemark)
    • NHSM 2011 (Bergen, Norway)
    • NHSM 2010 (Uppsala, Sweden)
  • Moral Support
    • Family support
    • The march toward healing
    • Be happy
    • I Had Cancer: You are not alone
    • Where to get help and support
    • Dances at the Cancer Research Centre
    • Magnificent - Beauty of nature
    • The spoon theory
    • Stronger
  • Patient Rights
  • Links to other sites, forums and Facebook
    • Sites ( English and other languages)
    • Forums
    • CML on Facebook
    • CML on Twitter
    • Audio Podcast
  • Specialist Journals in Hematology/Oncology
  • International publications
    • Publications from Africa
    • Publications from America
    • Publications from Australia
    • Publications from Asia
    • Publications from Europe
  • Foundations
    • Leukemia Foundations>
      • American Cancer Society
    • Hospital Foundations
  • CML Glossaries
  • Educational events
  • Educational videos
    • Educational videos (in English)
    • Educación de vídeos en español (in Spanish)
    • Vidéos pédagogiques en français (in French)
  • About us
  • Guestbook
  • Comments
Chronic Myeloid Leukemia

Dr. Pierre Laneuville

            ''Dr. Pierre Laneuville is an Associate Professor (GFT-U) in the Department of Medicine and Oncology at McGill University and the former Head of Hematology for the McGill University Health Center.
            Dr. Laneuville obtained an Honours B.Sc. at McMaster University, his medical degree at the University of Ottawa, trained in internal Medicine at McGill University, and completed his hematology sub-specialty and research training with Dr. B.A. Cooper at the Royal Victoria Hospital and McGill University from 1985 to 1989. He then joined the staff and faculty at the Royal Victoria Hospital and McGill University and has focused his clinical and laboratory research activities on hematological malignancies. 
            Dr Laneuville is best known for his research on the molecular mechanisms underlying the genesis and transformation of chronic myelogenous leukemia. He is the current President of the Canadian Hematological Society and Chairman of the Canadian Consensus Group on the Management of Chronic Myeloid Leukemia (CCGM-CML). He has served on numerous basic and clinical research panels including the Medical Research Council of Canada, the Leukemia Research Fund of Canada, the National Cancer Institute of Canada Clinical Trials Hematology Executive, and the Canadian Blood and Marrow Transplant Group. 
             He has held a number of research grants supported by the MRC, LRFC, CRSI, MSSC, and is actively engaged in clinical trials for hematological malignancies and stem cell transplantation. Dr. Laneuville serves on the Honorary Medical Board of the Leukemia Research Fund of Canada, and is a member of various Ministerial Advisory Committees related to blood transfusion and transfusion safety''
Extract of  Canadian Hematology Society
Picture

PCR and monitoring CML                 VIDEO
presented by Dr. Pierre Laneuville
A patient education video  from the  CML Society of Canada

Leukemia patient, cord cell recipient

La Banque clinico-recherche de sang de cordon du CUSM / MUHC Clinical Research Cord Blood Bank                                               VIDEO
'Ms. Linda Peltier will be responsible for the administrative management of the Cord Blood Bank, while Dr. Pierre Laneuville will act as medical director for the laboratory. Dr. Richard Brown will oversee the obstetrics component of the project.'
November 2009, MUHC Clinical Research Cord Blood Bank

Clinicals trial (hematologic)
McGill University Clinical Research Program, Department of Oncology

ARTICLES

High Risk of Error in Categorizing  Treatment Response in Individual CML Patients by Standard Cytogenetic Analysis  or PCR Assay with High CV: A Bayesian Analysis

December 10, 2012,  ASH 2012

                                           
Create a free website with Weebly